• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮粉末免疫的佐剂化

Adjuvantation of epidermal powder immunization.

作者信息

Chen D, Erickson C A, Endres R L, Periwal S B, Chu Q, Shu C, Maa Y F, Payne L G

机构信息

PowderJect Vaccines Inc., 585 Science Drive, Madison, WI 53711, USA.

出版信息

Vaccine. 2001 Apr 6;19(20-22):2908-17. doi: 10.1016/s0264-410x(00)00544-2.

DOI:10.1016/s0264-410x(00)00544-2
PMID:11282202
Abstract

The skin is an immunologically active site and an attractive vaccination route. All current vaccines, however, are administered either orally, intramuscularly, or subcutaneously. We previously reported that epidermal powder immunization (EPI) with an extremely small dose of powdered influenza vaccine induces protective immunity in mice. In this study, we report that commonly used adjuvants can be used in EPI to further enhance the immune responses to an antigen. The IgG antibody response to diphtheria toxoid (DT) following EPI was augmented by 25- and 250-fold, when 1 microg DT was co-delivered with aluminum phosphate (alum) and a synthetic oligonucleotide containing CpG DNA motifs (CpG DNA), respectively. These antibodies had toxin-neutralization activity and were long lasting. Furthermore, EPI using an adjuvant selectively activated different subsets of T helper cells and gave either a Th1 or a Th2 type of immune response. Similar to needle injection into deeper tissues, EPI with alum adsorbed DT promoted a predominantly IgG1 subclass antibody response and elevated level of IL-4 secreting cells. These are indicative of Th2-type immunity. In contrast, co-delivery of CpG DNA adjuvant via EPI led to Th-1 type of response as characterized by the increased production of IgG2a antibodies and IFN-gamma secreting cells. This study indicated that EPI using appropriate adjuvants can produce an augmented antibody response and desirable cellular immune responses. EPI is a promising immunization method that may be used to administer a broad range of vaccines including vaccines with adjuvants.

摘要

皮肤是一个具有免疫活性的部位,也是一种有吸引力的疫苗接种途径。然而,目前所有的疫苗都是通过口服、肌肉注射或皮下注射给药的。我们之前报道过,用极少量的粉末状流感疫苗进行表皮粉末免疫(EPI)可在小鼠中诱导保护性免疫。在本研究中,我们报告了常用的佐剂可用于EPI,以进一步增强对抗原的免疫反应。当1微克白喉类毒素(DT)分别与磷酸铝(明矾)和含有CpG DNA基序的合成寡核苷酸(CpG DNA)共同递送时,EPI后对DT的IgG抗体反应分别增强了25倍和250倍。这些抗体具有毒素中和活性且持久。此外,使用佐剂的EPI选择性地激活了不同的辅助性T细胞亚群,并产生了Th1或Th2型免疫反应。与注射到更深组织的针剂类似,用明矾吸附DT的EPI主要促进了IgG1亚类抗体反应,并提高了分泌IL-4细胞的水平。这些表明是Th2型免疫。相比之下,通过EPI共同递送CpG DNA佐剂导致了Th1型反应,其特征是IgG2a抗体和分泌IFN-γ细胞的产生增加。本研究表明,使用适当佐剂的EPI可产生增强的抗体反应和理想的细胞免疫反应。EPI是一种有前景的免疫方法,可用于接种多种疫苗,包括含佐剂的疫苗。

相似文献

1
Adjuvantation of epidermal powder immunization.表皮粉末免疫的佐剂化
Vaccine. 2001 Apr 6;19(20-22):2908-17. doi: 10.1016/s0264-410x(00)00544-2.
2
Immune responses to hepatitis B surface antigen following epidermal powder immunization.经表皮粉末免疫后对乙型肝炎表面抗原的免疫反应。
Immunol Cell Biol. 2003 Feb;81(1):52-8. doi: 10.1046/j.1440-1711.2003.01134.x.
3
Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment.在微针阵列预处理后,佐剂与白喉类毒素联合局部给药对BALB/c小鼠进行免疫调节。
Pharm Res. 2009 Jul;26(7):1635-43. doi: 10.1007/s11095-009-9874-6. Epub 2009 Mar 27.
4
Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.开发纳米颗粒佐剂以增强对白喉类毒素的免疫反应。
Hum Antibodies. 2018 Feb 5;26(2):75-85. doi: 10.3233/HAB-170324.
5
Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.经表皮粉末免疫诱导产生的针对灭活流感病毒疫苗的血清和黏膜免疫反应。
J Virol. 2001 Sep;75(17):7956-65. doi: 10.1128/jvi.75.17.7956-7965.2001.
6
RLJ-NE-299A: a new plant based vaccine adjuvant.RLJ-NE-299A:一种新型植物源疫苗佐剂。
Vaccine. 2007 Mar 30;25(14):2706-15. doi: 10.1016/j.vaccine.2006.06.036. Epub 2006 Jul 10.
7
Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.用铝非吸附白喉类毒素与重组霍乱毒素B亚单位作为佐剂经鼻内免疫小鼠后诱导全身和黏膜抗体反应。
Vaccine. 1999 Nov 12;18(7-8):743-51. doi: 10.1016/s0264-410x(99)00258-3.
8
Oral vaccine models: multiple delivery systems employing tetanus toxoid.口服疫苗模型:采用破伤风类毒素的多种递送系统。
Ann N Y Acad Sci. 1994 Aug 15;730:217-34. doi: 10.1111/j.1749-6632.1994.tb44251.x.
9
Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.在存在抗重组霍乱毒素B亚基(rCTB)抗体的情况下,频繁经鼻给予含rCTB的破伤风和白喉类毒素疫苗可诱导抗原特异性血清和黏膜免疫反应。
Vaccine. 2003 Jun 20;21(21-22):2954-63. doi: 10.1016/s0264-410x(03)00114-2.
10
The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid.含非甲基化CpG基序的寡脱氧核苷酸对卡介苗和白喉类毒素的黏膜佐剂性。
Vaccine. 2009 Feb 18;27(8):1166-73. doi: 10.1016/j.vaccine.2008.12.025. Epub 2009 Jan 9.

引用本文的文献

1
Development of thermostable vaccine adjuvants.耐热疫苗佐剂的开发。
Expert Rev Vaccines. 2021 May;20(5):497-517. doi: 10.1080/14760584.2021.1902314. Epub 2021 Jun 26.
2
Needle-Free Immunization with Chitosan-Based Systems.无针免疫接种用壳聚糖体系。
Int J Mol Sci. 2018 Nov 19;19(11):3639. doi: 10.3390/ijms19113639.
3
Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production.基于Toll样受体配体的疫苗佐剂需要抗原呈递细胞中完整的MyD88信号传导来形成生发中心和产生抗体。
Front Immunol. 2017 Mar 3;8:225. doi: 10.3389/fimmu.2017.00225. eCollection 2017.
4
Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles.白喉毒素CRM197突变体在掺钾羟基磷灰石微粒上的无针真皮递送
Clin Vaccine Immunol. 2015 May;22(5):586-92. doi: 10.1128/CVI.00121-15. Epub 2015 Mar 25.
5
Needle-free injection of insulin powder: delivery efficiency and skin irritation assessment.胰岛素粉末的无针注射:给药效率与皮肤刺激性评估
J Zhejiang Univ Sci B. 2014 Oct;15(10):888-99. doi: 10.1631/jzus.B1400065.
6
Skin immunization with influenza vaccines.皮内接种流感疫苗。
Curr Top Microbiol Immunol. 2015;386:343-69. doi: 10.1007/82_2014_407.
7
Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge.皮内接种佐剂流感疫苗可引发强大的长期免疫应答,从而提供针对致死性挑战的保护。
PLoS One. 2010 May 28;5(5):e10897. doi: 10.1371/journal.pone.0010897.
8
Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.喷雾包衣在生物制药粉末制剂中的应用:超越传统规模及其应用。
Pharm Res. 2004 Mar;21(3):515-23. doi: 10.1023/B:PHAM.0000019307.27058.a1.
9
Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization.用于表皮粉末免疫的明矾吸附疫苗粉末制剂的优化。
Pharm Res. 2003 Jul;20(7):969-77. doi: 10.1023/a:1024493719236.
10
Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.用合成肽在裸露皮肤上进行免疫接种:用含CpG的寡脱氧核苷酸进行免疫调节及对流感病毒特异性CD4 + T细胞的有效启动
Immunology. 2002 Feb;105(2):204-12. doi: 10.1046/j.0019-2805.2001.01357.x.